Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.

The Gastrointestinal (GI) Oncology Program at Weill Cornell Medicine and NewYork-Presbyterian is dedicated to providing state-of-the-art personalized care across the entire spectrum of cancers of the digestive system.   

Our team works relentlessly to improve the lives of people with gastrointestinal cancer. We pride ourselves on putting patients first, tailoring treatment to each individual’s unique needs in order to maximize health outcomes and minimize potential side effects of therapy.

Additionally, we are actively involved in biomedical research to advance drug development in gastrointestinal malignancies, leading worldwide clinical trials and collaborating with our on-site laboratories to bring novel therapies to patients.

From diagnosis to treatment and beyond, our experts at the GI Oncology Program will be with you every step of the way.